LeMaitre Vascular Inc (LMAT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, LeMaitre Vascular Inc (LMAT) has a cash flow conversion efficiency ratio of 0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($15.09 Million) by net assets ($406.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of LeMaitre Vascular Inc to measure how much of total assets are equity-financed.
LeMaitre Vascular Inc - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how LeMaitre Vascular Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check LMAT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
LeMaitre Vascular Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LeMaitre Vascular Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SIRIUSPOINT LTD. DL-10
F:3XPA
|
-0.011x |
|
Greif Inc
NYSE:GEF-B
|
0.038x |
|
Navinfo Co Ltd
SHE:002405
|
-0.018x |
|
Stadler Rail AG
SW:SRAIL
|
0.333x |
|
Fibocom Wireless Inc
SHE:300638
|
0.051x |
|
Nova Minerals Ltd
AU:NVA
|
-0.028x |
|
Jonjee Hi-tech Industrial and Commercial Holding Co Ltd
SHG:600872
|
0.045x |
|
Teekay Tankers Ltd
NYSE:TNK
|
0.039x |
Annual Cash Flow Conversion Efficiency for LeMaitre Vascular Inc (2004–2025)
The table below shows the annual cash flow conversion efficiency of LeMaitre Vascular Inc from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see LeMaitre Vascular Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $393.52 Million | $81.25 Million | 0.206x | +57.83% |
| 2024-12-31 | $337.29 Million | $44.12 Million | 0.131x | +6.04% |
| 2023-12-31 | $297.90 Million | $36.75 Million | 0.123x | +30.38% |
| 2022-12-31 | $268.20 Million | $25.38 Million | 0.095x | -31.49% |
| 2021-12-31 | $254.15 Million | $35.10 Million | 0.138x | -31.51% |
| 2020-12-31 | $172.57 Million | $34.80 Million | 0.202x | +110.69% |
| 2019-12-31 | $148.14 Million | $14.18 Million | 0.096x | -36.10% |
| 2018-12-31 | $130.24 Million | $19.51 Million | 0.150x | -28.11% |
| 2017-12-31 | $109.77 Million | $22.87 Million | 0.208x | +7.89% |
| 2016-12-31 | $87.50 Million | $16.90 Million | 0.193x | +31.48% |
| 2015-12-31 | $77.88 Million | $11.44 Million | 0.147x | +81.73% |
| 2014-12-31 | $68.21 Million | $5.51 Million | 0.081x | -15.16% |
| 2013-12-31 | $56.56 Million | $5.39 Million | 0.095x | +6.69% |
| 2012-12-31 | $52.89 Million | $4.72 Million | 0.089x | +46.71% |
| 2011-12-31 | $52.09 Million | $3.17 Million | 0.061x | -54.82% |
| 2010-12-31 | $52.36 Million | $7.05 Million | 0.135x | +19.37% |
| 2009-12-31 | $48.21 Million | $5.44 Million | 0.113x | +788.45% |
| 2008-12-31 | $45.75 Million | $581.00K | 0.013x | +133.79% |
| 2007-12-31 | $48.59 Million | $-1.83 Million | -0.038x | -262.25% |
| 2006-12-31 | $50.70 Million | $-526.00K | -0.010x | +84.00% |
| 2005-12-31 | $18.54 Million | $-1.20 Million | -0.065x | -157.11% |
| 2004-12-31 | $14.81 Million | $1.68 Million | 0.114x | -- |
About LeMaitre Vascular Inc
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arte… Read more